002793 罗欣药业
已收盘 04-29 15:00:00
资讯
新帖
简况
罗欣药业：截止至2026年4月20日，公司股东总户数为34,749
证券之星 · 04-27 16:06
罗欣药业：截止至2026年4月20日，公司股东总户数为34,749
4月23日罗欣药业现4085.05万元大宗交易
证券之星 · 04-23
4月23日罗欣药业现4085.05万元大宗交易
罗欣药业：公司正推进降本增效、聚焦主业优化结构
证券之星 · 04-23
罗欣药业：公司正推进降本增效、聚焦主业优化结构
罗欣药业最新公告：第一季度净利润同比增长327.35%
证券之星 · 04-22
罗欣药业最新公告：第一季度净利润同比增长327.35%
罗欣药业：截止至2026年4月10日，公司股东总户数为35,630
证券之星 · 04-14
罗欣药业：截止至2026年4月10日，公司股东总户数为35,630
股市必读：罗欣药业（002793）4月3日董秘有最新回复
证券之星 · 04-07
股市必读：罗欣药业（002793）4月3日董秘有最新回复
罗欣药业：公司在2025年9月30日已披露了《2025年度向特定对象发行A股股票预案》
证券之星 · 04-01
罗欣药业：公司在2025年9月30日已披露了《2025年度向特定对象发行A股股票预案》
罗欣药业：截止至2026年3月20日，公司股东总户数为36,067
证券之星 · 03-23
罗欣药业：截止至2026年3月20日，公司股东总户数为36,067
罗欣药业（002793）披露为控股子公司提供担保进展公告，3月20日股价下跌2.31%
证券之星 · 03-20
罗欣药业（002793）披露为控股子公司提供担保进展公告，3月20日股价下跌2.31%
罗欣药业：截止至2026年3月10日，公司股东总户数为36,780
证券之星 · 03-11
罗欣药业：截止至2026年3月10日，公司股东总户数为36,780
罗欣药业(002793)2月27日股东户数3.69万户，较上期减少1.95%
证券之星 · 03-02
罗欣药业(002793)2月27日股东户数3.69万户，较上期减少1.95%
【市场】17个国谈药拟进院，独家品种霸屏
米内网 · 02-25
【市场】17个国谈药拟进院，独家品种霸屏
罗欣药业：公司最新一期（2026年2月13日）股东总户数为37,614
证券之星 · 02-24
罗欣药业：公司最新一期（2026年2月13日）股东总户数为37,614
罗欣药业：截止至2026年2月10日，公司股东总户数为38,789
证券之星 · 02-11
罗欣药业：截止至2026年2月10日，公司股东总户数为38,789
罗欣药业：注射用LX22001目前已进入Ⅱ期临床试验阶段
证券之星 · 02-02
罗欣药业：注射用LX22001目前已进入Ⅱ期临床试验阶段
股市必读：罗欣药业（002793）预计2025年全年归属净利润亏损2.5亿元至3.4亿元
证券之星 · 02-02
股市必读：罗欣药业（002793）预计2025年全年归属净利润亏损2.5亿元至3.4亿元
罗欣药业2025年业绩预告释放了哪些信号？
中金财经 · 01-30
罗欣药业2025年业绩预告释放了哪些信号？
股市必读：罗欣药业（002793）1月28日董秘有最新回复
证券之星 · 01-29
股市必读：罗欣药业（002793）1月28日董秘有最新回复
罗欣药业：截止至2026年1月20日股东总户数为38,213
证券之星 · 01-21
罗欣药业：截止至2026年1月20日股东总户数为38,213
罗欣药业低价“甩卖”子公司引争议，“止血”背后藏匿多重风险
新浪证券 · 01-16
罗欣药业低价“甩卖”子公司引争议，“止血”背后藏匿多重风险
加载更多
公司概况
公司名称：
罗欣药业集团股份有限公司
所属行业：
医药制造业
上市日期：
2016-04-15
主营业务：
罗欣药业集团股份有限公司的主营业务是医药产品的研发、生产与销售。公司的主要产品是消化系统类、抗生素类、呼吸系统类、其他类、代理产品。
发行价格：
11.97
{"stockData":{"symbol":"002793","market":"SZ","secType":"STK","nameCN":"罗欣药业","latestPrice":5.39,"timestamp":1777446234000,"preClose":5.51,"halted":0,"volume":54778287,"delay":0,"changeRate":-0.0218,"floatShares":1086000000,"shares":1088000000,"eps":-0.2484,"marketStatus":"已收盘","change":-0.12,"latestTime":"04-29 15:00:00","open":5.37,"high":5.45,"low":5.32,"amount":295000000,"amplitude":0.0236,"askPrice":5.39,"askSize":2596,"bidPrice":5.38,"bidSize":1764,"shortable":0,"etf":0,"ttmEps":-0.2484,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777512600000},"marketStatusCode":5,"adr":0,"adjPreClose":5.51,"symbolType":"stock","openAndCloseTimeList":[[1777426200000,1777433400000],[1777438800000,1777446000000]],"highLimit":6.06,"lowLimit":4.96,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1087588486,"isCdr":false,"pbRate":5.45,"roa":"--","roe":"2.11%","epsLYR":-0.2718,"committee":-0.007201,"marketValue":5862000000,"turnoverRate":0.0504,"status":1,"floatMarketCap":5853000000},"requestUrl":"/m/hq/s/002793","defaultTab":"news","newsList":[{"id":"2630365536","title":"罗欣药业：截止至2026年4月20日，公司股东总户数为34,749","url":"https://stock-news.laohu8.com/highlight/detail?id=2630365536","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630365536?lang=zh_cn&edition=full","pubTime":"2026-04-27 16:06","pubTimestamp":1777277167,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)04月27日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止至2026年4月20日 股东人数是多少罗欣药业回复：尊敬的投资者，您好！截止至2026年4月20日，公司股东总户数为34,749。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700027228.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","002793","BK0201","BK0239","BK0001","08058"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629388145","title":"4月23日罗欣药业现4085.05万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2629388145","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629388145?lang=zh_cn&edition=full","pubTime":"2026-04-23 17:20","pubTimestamp":1776936053,"startTime":"0","endTime":"0","summary":"证券之星消息，4月23日罗欣药业发生大宗交易，交易数据如下：近三个月该股共发生2笔大宗交易，合计成交7.4万手，折价成交2笔。该股近期无解禁股上市。截至2026年4月23日收盘，罗欣药业(002793)报收于5.63元，上涨9.96%，涨停，换手率4.63%，成交量50.23万手，成交额2.76亿元。该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300047313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","BK0239","08058","002793","BK0201","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629056790","title":"罗欣药业：公司正推进降本增效、聚焦主业优化结构","url":"https://stock-news.laohu8.com/highlight/detail?id=2629056790","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629056790?lang=zh_cn&edition=full","pubTime":"2026-04-23 11:36","pubTimestamp":1776915393,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)04月23日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好公司连续四年亏损；是否有降本增效办法；比如是否裁员呢罗欣药业回复：尊敬的投资者您好！公司正推进降本增效、聚焦主业优化结构，人员随业务合理调整，核心团队稳定，全力改善经营业绩。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300031546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","BK0239","08058","002793","BK0201","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629104318","title":"罗欣药业最新公告：第一季度净利润同比增长327.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629104318","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629104318?lang=zh_cn&edition=full","pubTime":"2026-04-22 19:31","pubTimestamp":1776857488,"startTime":"0","endTime":"0","summary":"罗欣药业(002793.SZ)公告称，2026年第一季度实现营业收入5.83亿元，同比增长20.72%；归属于上市公司股东的净利润为2415.01万元，同比增长327.35%。业绩变动主要系核心创新药替戈拉生片市场覆盖率与终端动销水平持续提升，产品结构优化带动综合毛利率显著改善，以及处置罗欣安若维他部分股权形成投资收益所致。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200047771.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","08058"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627249606","title":"罗欣药业：截止至2026年4月10日，公司股东总户数为35,630","url":"https://stock-news.laohu8.com/highlight/detail?id=2627249606","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627249606?lang=zh_cn&edition=full","pubTime":"2026-04-14 11:34","pubTimestamp":1776137698,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)04月13日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截止到2026年4月10日公司股东人数是多少？谢谢！罗欣药业回复：尊敬的投资者，您好！截止至2026年4月10日，公司股东总户数为35,630。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041400016045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0132","08058","BK0239","BK0001","002793"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625059676","title":"股市必读：罗欣药业（002793）4月3日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2625059676","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625059676?lang=zh_cn&edition=full","pubTime":"2026-04-07 02:28","pubTimestamp":1775500092,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，罗欣药业报收于5.04元，下跌1.56%，换手率2.19%，成交量23.83万手，成交额1.21亿元。关于独立董事任期届满离任暨补选独立董事的公告罗欣药业独立董事许霞女士因任期届满即将离任，其离任将在公司股东会选举新任独立董事后生效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700000976.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","08058","002793","BK0132","BK0201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624564457","title":"罗欣药业：公司在2025年9月30日已披露了《2025年度向特定对象发行A股股票预案》","url":"https://stock-news.laohu8.com/highlight/detail?id=2624564457","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624564457?lang=zh_cn&edition=full","pubTime":"2026-04-01 11:36","pubTimestamp":1775014588,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)03月31日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，公司于2025年披露的向特定对象发行股票预案，目前定增事项是否已完成？是否已完成缴款、验资及股份登记上市？请说明最新进展。罗欣药业回复：尊敬的投资者，您好！感谢您对公司向特定对象发行股票事项的关注，公司在2025年9月30日已披露了《2025年度向特定对象发行A股股票预案》。后续进展敬请关注公司在指定信披媒体上披露的公告。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100018625.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399300","BK0132","159982","BK0239","002793","BK0201","BK0001","08058"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621775314","title":"罗欣药业：截止至2026年3月20日，公司股东总户数为36,067","url":"https://stock-news.laohu8.com/highlight/detail?id=2621775314","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621775314?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:03","pubTimestamp":1774252988,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)03月23日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止3月20日公司股东人数是多少？罗欣药业回复：尊敬的投资者，您好！截止至2026年3月20日，公司股东总户数为36,067。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300023142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","002793","BK0201","08058","BK0001"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620971784","title":"罗欣药业（002793）披露为控股子公司提供担保进展公告，3月20日股价下跌2.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620971784","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620971784?lang=zh_cn&edition=full","pubTime":"2026-03-20 17:37","pubTimestamp":1773999471,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，罗欣药业报收于4.65元，较前一交易日下跌2.31%，最新总市值为50.57亿元。近日，罗欣药业集团股份有限公司与中国建设银行股份有限公司临沂罗庄支行签署《本金最高额保证合同》，为控股子公司山东罗欣药业集团股份有限公司提供最高额人民币1.2亿元的连带责任保证担保。担保后，公司对山东罗欣的担保余额为121,439.37万元，山东罗欣可用担保额度剩余21,825.65万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000030866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0001","08058","BK0132","002793","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618121911","title":"罗欣药业：截止至2026年3月10日，公司股东总户数为36,780","url":"https://stock-news.laohu8.com/highlight/detail?id=2618121911","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618121911?lang=zh_cn&edition=full","pubTime":"2026-03-11 15:48","pubTimestamp":1773215286,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)03月11日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！请问公司截至3月10日的股东人数是多少？谢谢罗欣药业回复：尊敬的投资者，您好！截止至2026年3月10日，公司股东总户数为36,780。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100022278.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","08058","BK0201","002793","BK0001","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616387954","title":"罗欣药业(002793)2月27日股东户数3.69万户，较上期减少1.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616387954","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616387954?lang=zh_cn&edition=full","pubTime":"2026-03-02 17:30","pubTimestamp":1772443853,"startTime":"0","endTime":"0","summary":"证券之星消息，近日罗欣药业披露，截至2026年2月27日公司股东户数为3.69万户，较2月13日减少735.0户，减幅为1.95%。在化学制药行业个股中，罗欣药业股东户数高于行业平均水平，截至2月27日，化学制药行业平均股东户数为3.42万户。从股价来看，2026年2月13日至2026年2月27日，罗欣药业区间涨幅为1.44%，在此期间股东户数减少735.0户，减幅为1.95%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200025586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","BK0201","BK0239","BK0132","08058","BK0001"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614554709","title":"【市场】17个国谈药拟进院，独家品种霸屏","url":"https://stock-news.laohu8.com/highlight/detail?id=2614554709","media":"米内网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614554709?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:07","pubTimestamp":1772006826,"startTime":"0","endTime":"0","summary":"精彩内容近日，成都市第六人民医院发布招标公示，将组织拟引入药品生产企业遴选工作。17个新药在列，均为国谈药，涵盖化学药及生物药，既有环泊酚注射液等超10亿大品种，亦有芦比前列酮软胶囊、替戈拉生片等2025年前三季度销售额增速达三位数的高增长品种。17个新药均为国谈药，目前均已纳入国家医保乙类目录，主要集中在消化系统及代谢、神经系统、心脑血管系统等治疗领域，可见以慢病药、常见病药为主。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602251615059541ed56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602251615059541ed56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756325.SGD","BK4007","002653","BK4588","LU0154236417.USD","NVOH","BK4599","NVS","LU1093756168.USD","01276","NVOX","BK4532","600276","NVO","BK4585","002793","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2613798736","title":"罗欣药业：公司最新一期（2026年2月13日）股东总户数为37,614","url":"https://stock-news.laohu8.com/highlight/detail?id=2613798736","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613798736?lang=zh_cn&edition=full","pubTime":"2026-02-24 15:51","pubTimestamp":1771919475,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)02月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止到2月20日（2月13日收盘）公司的股东人数是多少？谢谢罗欣药业回复：尊敬的投资者，您好！公司最新一期（2026年2月13日）股东总户数为37,614。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400025897.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","002793","BK0132","BK0239","BK0001","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610060106","title":"罗欣药业：截止至2026年2月10日，公司股东总户数为38,789","url":"https://stock-news.laohu8.com/highlight/detail?id=2610060106","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610060106?lang=zh_cn&edition=full","pubTime":"2026-02-11 11:34","pubTimestamp":1770780869,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)02月11日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘你好，请问截止至2026年2月10日收盘公司股东人数为多少，谢谢！罗欣药业回复：尊敬的投资者，您好！截止至2026年2月10日，公司股东总户数为38,789。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021100014321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0132","BK0239","08058","BK0001","002793"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608385601","title":"罗欣药业：注射用LX22001目前已进入Ⅱ期临床试验阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2608385601","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608385601?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:18","pubTimestamp":1770020288,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)02月02日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司有没有最新前沿药物要发布？罗欣药业回复：尊敬的投资者，您好！公司重点研发的注射用LX22001目前已进入Ⅱ期临床试验阶段；普卡那肽片Ⅲ期临床研究报告已完成定稿，正在进行地产化落地；公司其他产品线布局情况请关注公司定期报告。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200021734.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","BK0001","BK0201","BK0132","BK0239","002793"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608897818","title":"股市必读：罗欣药业（002793）预计2025年全年归属净利润亏损2.5亿元至3.4亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608897818","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608897818?lang=zh_cn&edition=full","pubTime":"2026-02-02 03:56","pubTimestamp":1769975771,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，罗欣药业报收于4.84元，下跌0.82%，换手率1.27%，成交量13.83万手，成交额6699.43万元。业绩披露要点罗欣药业发布业绩预告，预计2025年全年归属净利润亏损2.5亿元至3.4亿元。业绩亏损主因包括上药罗欣业绩未达预期导致的公允价值变动损失、部分股权投资出现减值迹象，以及乐康制药等亏损业务在处置前的拖累。此外，公司于2026年1月29日召开职工代表大会，选举马少红为第六届董事会职工代表董事。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200001838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","002793"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607109049","title":"罗欣药业2025年业绩预告释放了哪些信号？","url":"https://stock-news.laohu8.com/highlight/detail?id=2607109049","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607109049?lang=zh_cn&edition=full","pubTime":"2026-01-30 22:07","pubTimestamp":1769782025,"startTime":"0","endTime":"0","summary":"1月30日，罗欣药业发布2025年业绩预告。报告期内，公司预计2025年度归属于母公司所有者的净利润将出现亏损，区间为万元至万元。与上年同期(万元)相比，亏损额预计大幅减少万元至万元，同比减亏幅度达%至%。 报告同时显示，罗欣药业2025年净利润大幅减亏的原因是其核心创新药产品替戈拉生片快速增长的拉动和产品结构和增长质量持续提升。 今天我们就借机来分析一下，罗欣药业这家老牌公司，当下及未来有哪些看点？","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260130/31988133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","BK0001","08058","BK0132","002793","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607744161","title":"股市必读：罗欣药业（002793）1月28日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2607744161","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607744161?lang=zh_cn&edition=full","pubTime":"2026-01-29 02:59","pubTimestamp":1769626748,"startTime":"0","endTime":"0","summary":"截至2026年1月28日收盘，罗欣药业报收于4.91元，下跌2.19%，换手率1.17%，成交量12.7万手，成交额6301.08万元。董秘最新回复投资者： 请问公司定增情况怎么样了？是否引入国资参与定增？目前公司定增工作正常推进中，后续进展请关注公司公告。当日关注点来自交易信息汇总：1月28日主力资金净流出210.99万元，散户资金净流入314.73万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900001652.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","002793","BK0001","BK0201","08058","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605439172","title":"罗欣药业：截止至2026年1月20日股东总户数为38,213","url":"https://stock-news.laohu8.com/highlight/detail?id=2605439172","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605439172?lang=zh_cn&edition=full","pubTime":"2026-01-21 16:57","pubTimestamp":1768985828,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)01月21日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问公司到1月20日的股东人数，谢谢罗欣药业回复：尊敬的投资者，您好！截止至2026年1月20日，公司股东总户数为38,213。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100027385.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","BK0239","BK0001","08058","BK0132","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603969552","title":"罗欣药业低价“甩卖”子公司引争议，“止血”背后藏匿多重风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2603969552","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603969552?lang=zh_cn&edition=full","pubTime":"2026-01-16 17:09","pubTimestamp":1768554540,"startTime":"0","endTime":"0","summary":"近日，罗欣药业（维权）一则转让控股子公司的公告引发市场关注。公司将以6250万元的价格将旗下乐康制药100%股权转让给成立仅两年、注册资本仅20万元的君康生物。而截至2025年9月30日，乐康制药净资产为7323.83万元，交易价明显低于净资产。 这笔“低价出售”背后，不仅暴露出标的公司持续亏损、资产萎缩的经营困境，也折射出罗欣药业近年来为扭亏频频剥离资产、债务压力渐显的复杂局面。 乐康制药并非罗欣药业近期出售的唯一资产。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-01-16/doc-inhhnzav3923248.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0001","08058","BK0132","002793","BK0201"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777471793184,"stockEarnings":[{"period":"1week","weight":0.0998},{"period":"1month","weight":0.1527},{"period":"3month","weight":0.1222},{"period":"6month","weight":0.0846},{"period":"1year","weight":0.2354},{"period":"ytd","weight":0.1479}],"compareEarnings":[{"period":"1week","weight":-0.0016},{"period":"1month","weight":0.0421},{"period":"3month","weight":-0.0175},{"period":"6month","weight":0.023},{"period":"1year","weight":0.2403},{"period":"ytd","weight":0.0277}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"罗欣药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"34749人(较上一季度减少2.47%)","perCapita":"31250股","listingDate":"2016-04-15","address":"山东省临沂市罗庄区罗七路18号4号楼","registeredCapital":"108758万元","survey":" 罗欣药业集团股份有限公司的主营业务是医药产品的研发、生产与销售。公司的主要产品是消化系统类、抗生素类、呼吸系统类、其他类、代理产品。","listedPrice":11.97},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"罗欣药业(002793)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供罗欣药业(002793)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"罗欣药业,002793,罗欣药业股票,罗欣药业股票老虎,罗欣药业股票老虎国际,罗欣药业行情,罗欣药业股票行情,罗欣药业股价,罗欣药业股市,罗欣药业股票价格,罗欣药业股票交易,罗欣药业股票购买,罗欣药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"罗欣药业(002793)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供罗欣药业(002793)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}